-
Mashup Score: 1
A panel of experts provide an overview of gene therapy, review recently approved gene therapies for rare diseases such as hemophilia, spinal muscular atrophy, and Duchenne muscular dystrophy, and discuss managed care considerations, focusing on the growing pipeline of therapies.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1Vitamin D Supplementation Linked to Reduced In-Hospital, ICU Mortality in Patients With COPD - 2 day(s) ago
Vitamin D supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (COPD), a study found.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
The FDA has approved fidanacogene elaparvovec-dzkt (Beqvez; Pfizer), a gene therapy administered in a one-time dose, for certain patients with moderate to severe hemophilia B.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1What We’re Reading: Kaiser Permanente Data Breach; GSK Sues Pfizer, BioNTech; HIV Infections via Cosmetic Injections - 2 day(s) ago
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0Melatonin Fails to Ease Fatigue in Patients With Early-Stage Breast Cancer Undergoing Radiotherapy - 3 day(s) ago
Melatonin showed no benefit for cancer-related fatigue or other symptoms in women with early-stage breast cancer receiving radiotherapy treatment.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Dr Ryan Stice Shares Strategy on Expanding Access to Care With Virtual Population Health Teams - 3 day(s) ago
In an interview during The American Journal of Managed Care®’s Institute for Value-Based Medicine® event, held with Sutter Health, Ryan Stice, PharmD, BCPS, explains the impact virtual population health teams can have on improving access to care for patients with cardiometabolic conditions.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0Talquetamab Cost-Effective Breakthrough for RRMM - 3 day(s) ago
The FDA granted accelerated approval to talquetamab on August 9, 2023, as a treatment option for adult patients with relapsed/refractory multiple myeloma (RRMM) who have failed at least 4 prior lines of therapy.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Optimizing BTK Inhibitors in CLL and SLL - 4 day(s) ago
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Source: www.ajmc.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0What We’re Reading: FTC Noncompete Ban Finalized; Unchecked Hospital Mergers Raised Health Costs; H5N1 Bird Flu Virus Particles Found - 4 day(s) ago
The Federal Trade Commission’s (FTC’s) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1Dr Robert Zimmerman Discusses Challenges, Adverse Effects of GLP-1 and Multi-Agonist Therapies - 4 day(s) ago
Robert Zimmerman, MD, discussed the adverse side effects associated with glucagon-like peptide-1 (GLP1) and multi-agonist therapies, as well as explored the challenges in developing these interventions.
Source: www.ajmc.comCategories: General Medicine News, PayerTweet-
Dr Robert Zimmerman of @ClevelandClinic recently discussed with #AJMC the adverse side effects associated with glucagon-like peptide-1 ( #GLP1 ) and multi-agonist therapies; he also explored the challenges in developing these interventions. Watch here: https://t.co/FaHfqV2gFS https://t.co/a3kaoZrIHQ
-
In this #PeerExchange, experts discuss recently approved gene therapies for rare diseases such as hemophilia, spinal muscular atrophy, and Duchenne muscular dystrophy, and review managed care considerations. Watch the series: https://t.co/mLqxO3M8AM #RareDisease #GeneTherapy